3573 results for «255»
3573 results
Rapid-fire clinical cases: Session 6
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of abstracts presented during PCR LV 2022: valve-in-valve implant in a dysfunctional tricuspid bioprosthesis, first patient in TRICURE FIH trial, challenging percutaneous closure of prosthetic paravalvular leaks, and more!
Rapid-fire clinical cases: Session 7
29 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: simultaneous transcatheter edge-to-edge repair of mitral and tricuspid valve, transcatheter valve implantation in mitral and tricuspid valve position, TEER failure in mitral and tricuspid position: troubleshooting approach for a rare but still eventful case,...
Complex scenarios during mitral valve-in-valve, valve-in-ring or valve-in-MAC procedures - a case-based approach
29 Nov 2022 – From PCR London Valves 2022
Discover some complex scenarios during mitral valve-in-valve, valve-in-ring or valve-in-MAC procedures with these presentations, and learn more about the essential role of TOE and CT imaging in predicting procedural complexity, the pre-emptive techniques and strategies to avoid left ventricular outflow tract obstruction as well as the bailout emergency techniques when...
PCR Live from London: episode 5
29 Nov 2022 – From PCR London Valves 2022
Consult this episode 5 of PCR Live from London to discover a presentation regarding simulation lab sessions, and learn more about the possible complications in TEER and their management.
Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the different needs of mitral and tricuspid patients, to appreciate what optimal medical therapy really means and to improve your knowledge of the anticoagulant requirements for different patient populations.
Rapid-fire abstracts: Session 7
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...
Transcatheter mitral valve interventions: clinical outcomes 1
28 Nov 2022 – From PCR London Valves 2022
Consult this session on transcatheter mitral valve interventions to discover a selection of abstracts submitted during PCR London Valves 2022: one-year outcomes for transcatheter mitral repair from the MiCLASP study, the Edwards PASCAL transcatheter mitral valve repair system study, one-year outcomes of Tendyne TMVR treating symptomatic MR,...
Rapid-fire clinical cases: Session 4
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: the buddy wire technique used with three different transcatheter heart valve systems, acute right coronary artery occlusion caused by calcium embolisation during TAVI, off-label temporary left ventricle haemodynamic support via Impella CP...
TAVI challenges: session 2
28 Nov 2022 – From PCR London Valves 2022
Watch this PCR LV 2022 session to learn how to treat TAVI with severe peripheral calcifications, a complex TAVI with extreme tortuous and horizontal aorta, or even TAVI in aortic regurgitation patient after failed attempt with commercial device.
Rapid-fire abstracts: Session 8
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: ultrasound-guided vs. conventional MANTA vascular closure device deployment after TAVR, novel aortic regurgitation quantification after Portico TAVI, mid-term outcome of TAVI using Myval transcatheter heart valve in severe bicuspid aortic stenosis, and...
TAVI challenges: session 3
28 Nov 2022 – From PCR London Valves 2022
View a radial access balloon aortic valvuloplasty adapting to the challenge of small arteries, a semi-inflated buddy balloon for percutaneous TAVR in severe calcified bicuspid aortic valve, and long-term outcome of TAVR in mucopolysaccharidosis type I-HS in this PCR LV 2022 session, among others!
Rapid-fire abstracts: Session 9
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of different aortic valve calcification pattern on the haemodynamic performance of self-expanding intra-annular transcatheter heart valve, device failure in bicuspid aortic stenosis following TAVR, the learning curve and clinical outcomes in...
Clinical outcomes after TAVI: Session 1
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about clinical outcomes after TAVI thanks to a selection of abstracts submitted during PCR LV 2022: definition of transcatheter heart valve orientation in bicuspid aortic valve with the DA VINCI study, TAVI with latest device iterations in patients with very...
Weird and wonderful!
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of cases presented during PCR LV 2022: endovascular treatment of aortic re-coarctation and giant aneurysm, percutaneous closure of a left ventricular pseudoaneurysm using transseptal approach, TAVI concomitant EVAR of distal aortic arch and closure of iatrogenic aorta-right ventricle fistula, and...
Mitral - Late-Breaking Trials and Innovations
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of late-breaking trials presented during PCR LV 2022: TENDyne European expeRience registry, CLASP IID trial, EXPAND G4, and much more!
Surgical and transcatheter tricuspid intervention: state of the art - LIVE case
29 Nov 2022 – From PCR London Valves 2022
In this PCR London Valves 2022 session, follow 3 stunning case treatments:
- Part 1: Triscupid TEER (Live)
A 78-year-old male with a history of CABG (2015), PM-CRT (2015) and atrial fibrillation, presents a severe TR with an LVEF of 40%, preserved RV function and moderate pulmonary hypertension.
They performed...
Imaging for mitral valve interventions
28 Nov 2022 – From PCR London Valves 2022
Thanks to this PCR LV 2022 session, find out more about outcome of patients undergoing transcatheter edge-to-edge mitral valve repair with HFpEF diagnosis.
Remaining unmet needs and strategies in TAVI
28 Nov 2022 – From PCR London Valves 2022
Watch this session to understand why valve design impacts future patient outcomes and how hemodynamics can impact decision-making and the durability of the TAVI devices. At the end of the session, you'll also get an overview of Medtronic's portfolio.
Technical challenges and optimal device choice for complex TAVI procedures
28 Nov 2022 – From PCR London Valves 2022
This session reflects on the importance of device choice and implantation technique in complex TAVI procedures. Learn how to anticipate the risks of a valve-in-valve procedure in small surgical prostheses, and discover the latest technological evolutions for treating patients with complex anatomy.
Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent, and VitaFlow valve
18 May 2022 – From EuroPCR 2022
The objective of this EuroPCR 2022 session is to highlight MicroPort's innovation portfolio in 3 different fields: learn more about the clinical performance of Firehawk Family stent in STEMI patients evaluated by imaging tools, the features and benefits of PCI robot R-ONE and first clinical trial updates in China,...
